Edwards Lifesciences EW Japan — Selling, general, and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's japan — selling, general, and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Edwards Lifesciences's japan — selling, general, and administrative expenses?
- Edwards Lifesciences (EW) reported japan — selling, general, and administrative expenses of $15.9M in Q1 2026.
- How has Edwards Lifesciences's japan — selling, general, and administrative expenses changed year-over-year?
- Edwards Lifesciences's japan — selling, general, and administrative expenses decreased by 3.0% year-over-year, from $16.4M to $15.9M.
- What is the long-term trend for Edwards Lifesciences's japan — selling, general, and administrative expenses?
- Over 3 years (2022 to 2025), Edwards Lifesciences's japan — selling, general, and administrative expenses has grown at a 0.5% compound annual growth rate (CAGR), from $77.4M to $78.5M.
- What does japan — selling, general, and administrative expenses mean?
- This metric aggregates the operating expenses required to support the sales, marketing, and administrative functions specifically for the Japanese business segment. It includes costs for sales force compensation, clinical education, and regional management overhead. Tracking this allows investors to evaluate the cost structure and operating leverage of the company's regional commercial infrastructure.